Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
January 25, 2012
Evaluation of IPPSE, an alternative method for sequential population PKPD analysis
B D Lacroix, L E Friberg, M O Karlsson
CPT: Pharmacometrics & Systems Pharmacology
|
October 30, 2014
Simultaneous Exposure-Response Modeling of ACR20, ACR50, and ACR70 Improvement Scores in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol
B D Lacroix, M O Karlsson, L E Friberg
The Journal of Pharmacology and Experimental Therapeutics
|
October 25, 2000
Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats
L E Friberg, A Freijs, M Sandström, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 30, 2010
Transforming parts of a differential equations system to difference equations as a method for run-time savings in NONMEM
K J F Petersson, L E Friberg, M O Karlsson
Clinical Pharmacology and Therapeutics
|
April 24, 2009
Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia
L E Friberg, R de Greef, T Kerbusch, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 6, 2017
A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients
E Schindler, M A Amantea, M O Karlsson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 15, 2016
PK-PD modeling of individual lesion FDG-PET response to predict overall survival in patients with sunitinib-treated gastrointestinal stromal tumor
E Schindler, M A Amantea, M O Karlsson, et al.
Clinical Pharmacology and Therapeutics
|
April 6, 2007
Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal
G K Isbister, L E Friberg, L P Hackett, et al.
European Journal of Clinical Pharmacology
|
January 11, 2001
Models of schedule dependent haematological toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC)
L E Friberg, C J Brindley, M O Karlsson, et al.
Clinical Pharmacology and Therapeutics
|
December 26, 2008
An agonist-antagonist interaction model for prolactin release following risperidone and paliperidone treatment
L E Friberg, A M Vermeulen, K J F Petersson, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Journal of Pharmacokinetics and Pharmacodynamics
|
January 25, 2012
Evaluation of IPPSE, an alternative method for sequential population PKPD analysis
B D Lacroix, L E Friberg, M O Karlsson
CPT: Pharmacometrics & Systems Pharmacology
|
October 30, 2014
Simultaneous Exposure-Response Modeling of ACR20, ACR50, and ACR70 Improvement Scores in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol
B D Lacroix, M O Karlsson, L E Friberg
The Journal of Pharmacology and Experimental Therapeutics
|
October 25, 2000
Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats
L E Friberg, A Freijs, M Sandström, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 30, 2010
Transforming parts of a differential equations system to difference equations as a method for run-time savings in NONMEM
K J F Petersson, L E Friberg, M O Karlsson
Clinical Pharmacology and Therapeutics
|
April 24, 2009
Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia
L E Friberg, R de Greef, T Kerbusch, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 6, 2017
A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients
E Schindler, M A Amantea, M O Karlsson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 15, 2016
PK-PD modeling of individual lesion FDG-PET response to predict overall survival in patients with sunitinib-treated gastrointestinal stromal tumor
E Schindler, M A Amantea, M O Karlsson, et al.
Clinical Pharmacology and Therapeutics
|
April 6, 2007
Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal
G K Isbister, L E Friberg, L P Hackett, et al.
European Journal of Clinical Pharmacology
|
January 11, 2001
Models of schedule dependent haematological toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC)
L E Friberg, C J Brindley, M O Karlsson, et al.
Clinical Pharmacology and Therapeutics
|
December 26, 2008
An agonist-antagonist interaction model for prolactin release following risperidone and paliperidone treatment
L E Friberg, A M Vermeulen, K J F Petersson, et al.
Page
of 4